Marilina Mastronardi

Marilina Mastronardi

Marilina Mastronardi

Biography

Mrs. Mastronardi is the Managing Director and Chief of Staff for State Street Global Advisors, Ltd. In addition to managing investment Operations, she coordinates other professional support functions in Canada. Prior responsibilities included Director of Finance, Administration and Compliance, having been responsible for the development and implementation of administrative and compliance functions. Preceding this, Mrs. Mastronardi worked with the investment Operations Team as a Senior Investment Accountant. She joined the firm in 1994. Mrs. Mastronardi received her Bachelor of Commerce in Accountancy from Concordia University in Montreal.

Overview
RelSci Relationships

29

Number of Boards

1

Relationships
RelSci Relationships are individuals Marilina Mastronardi likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder, Chairman & Chief Executive Officer at Sectoral Asset Management, Inc.

Relationship likelihood: Strong

Senior Partner at Sectoral Asset Management, Inc.

Relationship likelihood: Strong

Chairman-Australia at Lowenhaupt Global Advisors Holdings LLC

Relationship likelihood: Strong

Professional at The Bank of New York Mellon Corporation

Relationship likelihood: Strong

Former Director at Sectoral Asset Management, Inc.

Relationship likelihood: Strong

Former Member, Board of Directors at Sectoral Asset Management, Inc.

Relationship likelihood: Strong

Director at Sectoral Asset Management, Inc.

Relationship likelihood: Strong

Founding Partner at UBP-Gestion Institutionnelle SA

Relationship likelihood: Strong

Director at Sectoral Asset Management, Inc.

Relationship likelihood: Strong

Former Member, Board of Directors at Sectoral Asset Management, Inc.

Relationship likelihood: Strong

Paths to Marilina Mastronardi
Potential Connections via
Relationship Science
You
Marilina Mastronardi
Boards & Committees
Member, Board of Directors
Current

Sectoral is a fundamentals-based, medium- to long-term, GARP-oriented manager which focuses on companies in the healthcare (Pharmaceuticals, Generics, Biotechs and Medtechs) sector. They aim to achieve superior returns for investors by concentrating on primary research.The firm conducts preliminary research and analysis, including literature and documentation, interaction with companies and with Sectoral's Advisory Network, to identify investment candidates. They then conduct forecasting and scenario analyses, testing a range of assumptions and success factors critical to the company's success. They subsequently generate realistic valuation ranges for potential investments and assess the impact of the investment on the overall risk/return profile of the portfolio. They believe that specific risk is the most important risk component and have developed and refined their investment process to mitigate it.Their analysts attempt to determine the fair value for investment candidates as well as 1-year and 3-year price targets. Depending on the development stage of the company, they utilize models such as discounted cash-flow models, EBITDA models, classical growth models (PE approach), enterprise value/sales and peer group analysis to determine the price targets.Sectoral makes recommendations based on the resulting fair value to the current market value of each investment candidate and constructs portfolios comprised of analysts' investment recommendations. Their CIO determines the weight of each industry based on the attractiveness of expected growth, profitability, historic valuation and relative valuation.

Director
2012 - ?

Sectoral Asset Management specializes in managing global portfolios that invest in the healthcare sector. The firm employs a bottom-up investment approach that can be categorized as growth at a reasonable price (GARP). Investments are selected using a focused stock selection process based on primary research of company fundamentals and close contacts with company management to assess their scientific, business, financial and ESG aspects. Specific areas of interest include: Pharmaceuticals, Biotechs, Life Science Tools and Services, Medtechs and Healthcare Providers and Services, Healthcare Equipment and Supplies, and Healthcare Technology. Covered companies are blue-chips, main index constituents and companies with innovative programs identified through research and industry contacts, including recent IPOs. The investment process encompasses stock selection, portfolio construction and risk management.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Marilina Mastronardi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Marilina Mastronardi's profile does not indicate a business or promotional relationship of any kind between RelSci and Marilina Mastronardi.